Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

393
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
393
Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

395
 The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
395
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

368
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
368
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

425
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
425
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

6.4K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
6.4K
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

458
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
458

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnostic and Prognostic Utility of Mitral Annular Plane Systolic Excursion: A Systematic Review and Meta-Analysis.

Journal of the American Heart Association·2026
Same author

Effect of Bridging Stent Graft Selection on the Outcomes of Endovascular Aneurysm Repair using an Iliac Branch Device.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2026
Same author

Hybrid zone 1 repair of a giant post-traumatic intrathoracic left subclavian artery pseudoaneurysm.

Journal of vascular surgery cases and innovative techniques·2026
Same author

Microstructural disease and hypoperfusion in dilated cardiomyopathy underpin midwall septal fibrosis.

Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance·2026
Same author

Mid-term Outcomes of Four-Fenestrated Endovascular Aneurysm Repair Without Stenting of the Celiac Artery (The UNCAP Study): Insights From a Multicentric European Experience.

Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists·2026
Same author

Arch-First Technique for Extensive Thoracic Aortic Replacement: A Case Series of Patients With Complex Thoracic Aortic Disease.

The American journal of case reports·2026

Related Experiment Video

Updated: Feb 12, 2026

En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries
08:58

En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries

Published on: February 25, 2016

10.1K

Nitric oxide donors for peripheral artery disease.

Debbie Falconer1, Nikolaos Papageorgiou2, Karim Salem3

  • 1University College Hospital London, London, UK.

Current Opinion in Pharmacology
|March 28, 2018
PubMed
Summary

New treatments for peripheral arterial disease (PAD) are needed. Targeting the nitric oxide (NO) pathway, which regulates endothelial function, shows promise for improving symptoms like intermittent claudication.

More Related Videos

Platelet-based Detection of Nitric Oxide in Blood by Measuring VASP Phosphorylation
07:13

Platelet-based Detection of Nitric Oxide in Blood by Measuring VASP Phosphorylation

Published on: January 7, 2019

8.5K
Analytical Techniques for Assaying Nitric Oxide Bioactivity
11:28

Analytical Techniques for Assaying Nitric Oxide Bioactivity

Published on: June 18, 2012

18.5K

Related Experiment Videos

Last Updated: Feb 12, 2026

En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries
08:58

En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries

Published on: February 25, 2016

10.1K
Platelet-based Detection of Nitric Oxide in Blood by Measuring VASP Phosphorylation
07:13

Platelet-based Detection of Nitric Oxide in Blood by Measuring VASP Phosphorylation

Published on: January 7, 2019

8.5K
Analytical Techniques for Assaying Nitric Oxide Bioactivity
11:28

Analytical Techniques for Assaying Nitric Oxide Bioactivity

Published on: June 18, 2012

18.5K

Area of Science:

  • Cardiovascular Medicine
  • Vascular Biology
  • Pharmacology

Background:

  • Current peripheral arterial disease (PAD) management includes risk factor modification and revascularization, yet many patients experience persistent debilitating symptoms.
  • The nitric oxide (NO) pathway is crucial for endothelial function and has been a focus for treating vascular diseases, including PAD.
  • Statins and ACE inhibitors demonstrate NO-enhancing effects, improving intermittent claudication, while l-arginine studies yield inconsistent results.

Purpose of the Study:

  • To explore the potential of targeting the nitric oxide (NO) pathway as a novel therapeutic strategy for peripheral arterial disease (PAD).
  • To review existing evidence on interventions affecting the NO pathway and their impact on PAD symptoms.

Main Methods:

  • Literature review of studies investigating the role of nitric oxide (NO) in vascular function and PAD.
  • Analysis of clinical trial data on pharmacological interventions (statins, ACE inhibitors, l-arginine) affecting the NO pathway in PAD patients.
  • Examination of research on enzymatic control within the NO pathway for potential therapeutic targets.

Main Results:

  • Statins and ACE inhibitors have shown efficacy in enhancing endogenous nitric oxide (NO) and alleviating intermittent claudication symptoms in PAD patients.
  • Studies involving l-arginine supplementation have yielded variable outcomes, necessitating further investigation into underlying mechanisms.
  • Advances in understanding NO pathway regulation have identified new targets for therapeutic intervention.

Conclusions:

  • The nitric oxide (NO) pathway represents a promising avenue for developing new treatments for peripheral arterial disease (PAD).
  • Further research into the enzymatic control of NO levels is warranted to optimize therapeutic strategies for PAD.
  • Personalized approaches may be necessary to address the varied responses observed with interventions like l-arginine.